Idiopathic pulmonary fibrosis: Idiopathic pulmonary fibrosis is a lung disease in which lung tissue becomes thick and stiff, eventually forming scar tissue in the lungs. The scarring, or fibrosis, appears to result from a cycle of damage and healing that occurs in the lungs. These changes are irreversible, and the first symptoms may be shortness of breath or a dry cough. Idofnib 100 Capsule kills or stops the growth of cancer cells and also prevents cancer cells from multiplying. It is possible that you may experience some unpleasant side effects. Discuss this together along with your physician when you have any concerns. Interstitial lung disease: Interstitial lung disease (ILD) refers to a group of lung diseases that affect the interstitium, which is the tissue and space around the air sacs in the lungs. These conditions cause inflammation and scarring of the lung tissue, leading to difficulty in breathing. Idofnib Capsule kills or stops the growth of cancer cells and also prevents cancer cells from multiplying. You may additionally experience some unpleasant side effects. If you've got any concerns, please speak them together along with your doctor. Non-small cell lung cancer (NSCLC) Non-small cell lung cancer is one of the main types of lung cancer and affects both smokers and non-smokers. Idofnib 100 mg helps treat NSCLC and can be given alone or in combination with other medicines. It is a strong and very toxic medicine, and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol during this treatment and drink plenty of water to stay hydrated. Systemic sclerosis: Systemic sclerosis, commonly known as scleroderma, is an autoimmune disease that can affect various parts of the body, including the skin and internal organs. By reducing the progression of fibrosis, Idofnib 100 Capsule may help to maintain or preserve lung function, leading to better lung capacity and potentially slowing the decline in lung function.